Adler, L. A., Resnick, S., Kunz, M., & Devinsky, O. (1995). Open-label trial of venafaxine in adults with attention deficit disorder. Psychopharmacology Bulletin, 31, 785-788.
2.
Alpert, J. E., Maddocks, A., Nierenberg, A. A., O’Sullivan, R., Pava, J. A., Worthington, J. J., Biederman, J., Rosenbaum, J. F., & Fava, M. (1996). Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Research, 62, 213-219.
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4.
Biederman, J., Spencer, T., & Wilens, T. (1997). Psychopharmacology. In J. M. Wiener (Ed.), Textbook of child and adolescent psychiatry (2nd ed., pp. 779-812). Washington, DC: American Psychiatric Press.
5.
Cantwell, D. P. (1996). Attention deficit disorder: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 978-987.
Dulcan, M. K., & Benson, R. S. (1997). AACAP official action. Summary of the practice parameters for the assessment and treatment of children, adolescents and adults with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1311-1317.
8.
Findling, R. L., & Dogin, J. W. (1998). Psychopharmacology of ADHD: Children and adolescents. Journal of Clinical Psychiatry, 59(Suppl. 7), 42-49.
9.
Greenhill, L. L. (1998). Attention deficit hyper-activity disorder. In B. T. Walsh (Ed.), Child psychopharmacology (pp. 29-64). Washington, DC: American Psychiatric Press.
10.
McCraken, J. T. (1998) AD/HD II: Neuropsychiatric aspects. In C. E. Coffey & R. A. Brumback (Eds.), Textbook of pediatric neuropsychiatry (pp. 485-501). Washington, DC: American Psychiatric Press.
11.
Physician’s desk reference (54th ed). (2000). Montvale, NJ: Medical Economics.
12.
Ratney, J. R. (1999, Winter). An update on medications used in the treatment of attention deficit disorder. FOCUS [On-line]. Available: http://www.add.org/Focus/medupdate.htm
13.
Richters, J. E., Arnold, L. E., Jensen, P. S., Abikoff, H., Conners, C. K., Greenhill, L. L., Hechtman, L., Hinshaw, S. P., Pelham, W. E., & Swanson, J. M. (1995). NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 987-1000.
14.
Rube, D. (1998). Attention deficit hyperactivity disorder. In W. M. Klykylo, J. Kay, & D. Rube (Eds.), Clinical child psychiatry (pp. 117-155). Philadelphia: Saunders.
15.
Sallee, F. R., & Gill, H. S. (1998). Neuropsychopharmacology III: Psychostimulants. In C. E. Coffey & R. A. Brumback (Eds.), Textbook of pediatric neuropsychiatry (pp. 1351-1372). Washington, DC: American Psychiatric Press.
16.
Spencer, T., Biederman, J., Wilens, T., Harding, M., O’Donnell, D., & Griffith, S. (1996). Pharmacotherapy of ADHD across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432.
17.
Wender, P. H. (1998). Pharmacotherapy of ADHD in Adults. Journal of Clinical Psychiatry, 59(Suppl. 7), 76-79.
18.
Wilens, T. E. (1999). Straight talk about psychiatric medication for kids. Hartford, CT: The Guilford Press.
